Categories
Jagsonpal Pharmaceuticals Limited — Updates, 27-04-2026: Press Release
27-04-2026 · 07:44 am
Jagsonpal Pharmaceuticals shareholders approved a buyback of up to 1.6 Cr equity shares at ₹250/share, totaling ₹40 Cr. This move aims to optimize capital allocation and enhance shareholder value by improving EPS.
No comments yet. Be the first to comment!